These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 23500524
21. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro. Yang L, Tian Y, Leong WS, Song H, Yang W, Wang M, Wang X, Kong J, Shan B, Song Z. Breast Cancer Res; 2018 Sep 18; 20(1):113. PubMed ID: 30227879 [Abstract] [Full Text] [Related]
22. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway. Won HY, Lee JY, Shin DH, Park JH, Nam JS, Kim HC, Kong G. FASEB J; 2012 Dec 18; 26(12):5002-13. PubMed ID: 22954590 [Abstract] [Full Text] [Related]
23. Determination of the target proteins in chemotherapy resistant breast cancer stem cell-like cells by protein array. Kars MD, Yıldırım G. Eur J Pharmacol; 2019 Apr 05; 848():23-29. PubMed ID: 30707960 [Abstract] [Full Text] [Related]
24. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells]. Zhonghua Zhong Liu Za Zhi; 2015 Apr 05; 37(4):251-7. PubMed ID: 26462888 [Abstract] [Full Text] [Related]
25. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Sui M, Huang Y, Park BH, Davidson NE, Fan W. Cancer Res; 2007 Jun 01; 67(11):5337-44. PubMed ID: 17545614 [Abstract] [Full Text] [Related]
26. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation. In LL, Azmi MN, Ibrahim H, Awang K, Nagoor NH. Anticancer Drugs; 2011 Jun 01; 22(5):424-34. PubMed ID: 21346553 [Abstract] [Full Text] [Related]
27. [Growth of breast cancer cells is inhibited in vitro by cyclin E-siRNA]. He WS, Huang T, Ren JH. Zhonghua Zhong Liu Za Zhi; 2009 Mar 01; 31(3):170-3. PubMed ID: 19615252 [Abstract] [Full Text] [Related]
28. [Effect of combined use of PDTC and paclitaxel on proliferation and invasion of human breast cancer cell line MCF-7]. Yang C, Zhang H, Huang W, Lin Q, Wei H. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct 01; 27(5):1105-9. PubMed ID: 21089680 [Abstract] [Full Text] [Related]
29. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation. Glinka Y, Mohammed N, Subramaniam V, Jothy S, Prud'homme GJ. Biochem Biophys Res Commun; 2012 Sep 07; 425(4):775-80. PubMed ID: 22885184 [Abstract] [Full Text] [Related]
30. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway. Wang Z, Wang N, Li W, Liu P, Chen Q, Situ H, Zhong S, Guo L, Lin Y, Shen J, Chen J. Carcinogenesis; 2014 Oct 07; 35(10):2346-56. PubMed ID: 25085904 [Abstract] [Full Text] [Related]
31. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, Fu L, Dong JT. Oncotarget; 2016 Feb 02; 7(5):5702-14. PubMed ID: 26744318 [Abstract] [Full Text] [Related]
32. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. Wang Z, Goulet R, Stanton KJ, Sadaria M, Nakshatri H. Anticancer Res; 2005 Feb 02; 25(3c):2367-79. PubMed ID: 16080463 [Abstract] [Full Text] [Related]
33. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM. Cancer Chemother Pharmacol; 2008 Nov 02; 62(6):1045-54. PubMed ID: 18301895 [Abstract] [Full Text] [Related]
34. Short-hairpin RNA-mediated Heat shock protein 90 gene silencing inhibits human breast cancer cell growth in vitro and in vivo. Zuo K, Li D, Pulli B, Yu F, Cai H, Yuan X, Zhang X, Lv Z. Biochem Biophys Res Commun; 2012 May 04; 421(2):396-402. PubMed ID: 22521890 [Abstract] [Full Text] [Related]
35. Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance. Park EY, Chang E, Lee EJ, Lee HW, Kang HG, Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, Song E, Park JH. Cancer Res; 2014 Dec 15; 74(24):7573-82. PubMed ID: 25368020 [Abstract] [Full Text] [Related]
36. STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells. Newman SP, Foster PA, Stengel C, Day JM, Ho YT, Judde JG, Lassalle M, Prevost G, Leese MP, Potter BV, Reed MJ, Purohit A. Clin Cancer Res; 2008 Jan 15; 14(2):597-606. PubMed ID: 18223236 [Abstract] [Full Text] [Related]
37. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo. Wang X, Yuan S, Wang J, Lin P, Liu G, Lu Y, Zhang J, Wang W, Wei Y. Toxicol Appl Pharmacol; 2006 Sep 01; 215(2):168-78. PubMed ID: 16563451 [Abstract] [Full Text] [Related]
38. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells. Ju JH, Jang K, Lee KM, Kim M, Kim J, Yi JY, Noh DY, Shin I. Carcinogenesis; 2011 Oct 01; 32(10):1474-83. PubMed ID: 21798852 [Abstract] [Full Text] [Related]
39. [The effect of LAMP2A shRNA on the resistance of breast cancer cells to paclitaxel]. Han Q, Chen S, Yang M, Zhang Z, Chen A, Hu C, Li S. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Apr 01; 30(4):351-4. PubMed ID: 24721399 [Abstract] [Full Text] [Related]
40. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Qi X, Chang Z, Song J, Gao G, Shen Z. Anticancer Drugs; 2011 Jul 01; 22(6):556-62. PubMed ID: 21637162 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]